Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: Norway Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20101
20111
20122
20152
20172
20181
20191
20202
20223
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting5
Recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Oslo University Hospital3
European Organisation for Research and Treatment of Cancer - EORTC2
Vestre Viken Hospital Trust2
AstraZeneca1
BerGenBio ASA1
Daiichi Sankyo1
Eli Lilly and Company1
GlaxoSmithKline1
Partner Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung19
Lung Neoplasms6
Adenocarcinoma of Lung4
Neoplasms4
Melanoma3
Pancreatic Neoplasms2
Breast Neoplasms1
Carcinoma, Renal Cell1
Cutaneous Squamous Cell Carcinoma1
Endometrial Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.